Lobo Kevin
- SEC CIK
- 0001519419
In the past year, 1 open-market purchase filing worth $641.8K and no sales.
Current role at each company
- GEHC GE HealthCare Technologies Inc.Directoras of May 26, 2026
- SYK Stryker CorpChair and CEOas of Mar 24, 2026
- PH Parker-Hannifin CorpDirectoras of Dec 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $641.8K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$641.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lobo Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GEHC GE HealthCare Technologies Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing) | May 22 | 4 days | Lobo KevinDirector | PPurchaseCommon Stock, par value $0.01 per share | +10.0K | $64.18 | +$641.8K | +229.2%14.4K after |
SYK Stryker Corp
Chair and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 (view filing) | Nov 7 | 1 day | Lobo KevinChair and CEO | SSale | −57.3K | $368.70 | −$21.1M | −36.4%100.0K after | 3 lots |
| Nov 21, 2023 (view filing) | Nov 17 | 4 days | Lobo KevinChair and CEO | SSale | −56.5K | $287.91 | −$16.3M | −41.1%81.0K after | 4 lots |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Lobo KevinChair and CEO | SSale | −67.2K | $239.68 | −$16.1M | −45.4%80.8K after | 2 lots |